Back to results
US 2020/0368310 A1Published application
Treatment with nmda receptor modulators
AssigneeNaurex, Inc.
InventorsPradeep Banerjee, John Donello
Life of this patent
Estimating the term…
Abstract
Disclosed are methods for treating a patient suffering from (i) a cognitive, neurological or psychological disease or disorder; and (ii) a sleep disorder comprising the step of administering to said patient a therapeutically effective amount of an N-Methyl-D-aspartic acid (NMDA) receptor partial agonist, in particular rapastinel or a pharmaceutically acceptable salt, ester, prodrug or metabolite thereof.
Claims32
A method of treating a patient suffering from (i) a cognitive, neurological or psychological disease or disorder;
- and (ii) a sleep disorder or sleep disturbances, comprising the step of administering to said patient a therapeutically effective amount of an N-Methyl-D-aspartic acid (NMDA) receptor partial agonist.
(canceled)
(canceled)
(canceled)
32-44. (canceled)
Dependencies are inferred from the claim text.